Dicerna Pharmaceuticals, Inc. DRNA
$ 38.25
0.34%
Dicerna Pharmaceuticals, Inc. Balance Sheet 2011-2024 | DRNA
Annual Balance Sheet Dicerna Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-72.7 M | -129 M | -54.2 M | -68.8 M | -20.9 M | -56.1 M | -26.1 M | -41.7 M | 5.13 M | -10.9 M |
Long Term Debt |
48.7 M | - | - | - | - | - | - | 260 K | 4.66 M | 8.74 M |
Total Non Current Liabilities |
392 M | 203 M | 114 M | 3 M | - | - | 106 K | 111 M | 69.2 M | 70 M |
Total Current Liabilities |
178 M | 242 M | 94.1 M | 16.6 M | 10 M | 9 M | 5.16 M | 7.68 M | 5.67 M | 5.3 M |
Total Liabilities |
570 M | 445 M | 208 M | 19.6 M | 10 M | 9 M | 5.26 M | 119 M | 74.9 M | 75.3 M |
Deferred Revenue |
139 M | 212 M | 68.9 M | 6 M | - | - | - | - | - | 830 K |
Retained Earnings |
-638 M | -525 M | -405 M | -316 M | -256 M | -196 M | -133 M | -85.5 M | -64.7 M | -50.6 M |
Total Assets |
708 M | 597 M | 409 M | 121 M | 51.3 M | 100 M | 104 M | 49.8 M | 10.2 M | 24.6 M |
All numbers in USD currency